AAPL327.50+12.64 (+4.01%) ▲|ABBV244.22+1.17 (+0.48%) ▲|ABT89.35+1.02 (+1.15%) ▲|ACN137.07+2.51 (+1.87%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.60-0.23 (-0.14%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.48+3.42 (+0.96%) ▲|BA218.19+1.08 (+0.50%) ▲|BAC61.62+1.00 (+1.65%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.23+67.79 (+6.61%) ▲|BMY58.70+1.75 (+3.07%) ▲|BNY162.41+7.91 (+5.12%) ▲|BRK-B488.97-2.12 (-0.43%) ▼|C134.98+1.71 (+1.28%) ▲|CAT914.09-19.25 (-2.06%) ▼|CL91.46+0.43 (+0.47%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.47-0.40 (-0.36%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.57 (-0.34%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.90-0.28 (-0.26%) ▼|CVX181.66-0.10 (-0.06%) ▼|DE589.47+5.07 (+0.87%) ▲|DHR200.78+1.73 (+0.87%) ▲|DIS97.17+1.30 (+1.36%) ▲|DUK124.31-2.07 (-1.63%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.43-0.24 (-0.07%) ▼|GD365.66-3.84 (-1.04%) ▼|GE360.26+6.53 (+1.85%) ▲|GEV1,055.67-10.35 (-0.97%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.65+0.78 (+1.01%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.25+12.25 (+1.07%) ▲|HD341.56+3.82 (+1.13%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.18-5.89 (-2.71%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.03-6.82 (-2.69%) ▼|JPM347.02+4.13 (+1.20%) ▲|KO82.46-0.63 (-0.75%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.47+3.93 (+0.34%) ▲|LMT514.30-0.69 (-0.13%) ▼|LOW209.72+2.04 (+0.98%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.36-2.66 (-0.49%) ▼|MCD264.94-4.00 (-1.49%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.50+1.20 (+1.51%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.52+3.94 (+2.52%) ▲|MO70.51+0.35 (+0.50%) ▲|MRK123.60+2.82 (+2.33%) ▲|MS228.51+0.84 (+0.37%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.12-0.42 (-0.47%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.78-0.08 (-0.19%) ▼|NOW104.75-0.11 (-0.10%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.53+4.59 (+3.59%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.80+0.55 (+2.27%) ▲|PG148.01+1.93 (+1.32%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.87+4.92 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.59-1.37 (-1.43%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.27+1.20 (+0.22%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.50-0.59 (-0.41%) ▼|AAPL327.50+12.64 (+4.01%) ▲|ABBV244.22+1.17 (+0.48%) ▲|ABT89.35+1.02 (+1.15%) ▲|ACN137.07+2.51 (+1.87%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.60-0.23 (-0.14%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.48+3.42 (+0.96%) ▲|BA218.19+1.08 (+0.50%) ▲|BAC61.62+1.00 (+1.65%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.23+67.79 (+6.61%) ▲|BMY58.70+1.75 (+3.07%) ▲|BNY162.41+7.91 (+5.12%) ▲|BRK-B488.97-2.12 (-0.43%) ▼|C134.98+1.71 (+1.28%) ▲|CAT914.09-19.25 (-2.06%) ▼|CL91.46+0.43 (+0.47%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.47-0.40 (-0.36%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.57 (-0.34%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.90-0.28 (-0.26%) ▼|CVX181.66-0.10 (-0.06%) ▼|DE589.47+5.07 (+0.87%) ▲|DHR200.78+1.73 (+0.87%) ▲|DIS97.17+1.30 (+1.36%) ▲|DUK124.31-2.07 (-1.63%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.43-0.24 (-0.07%) ▼|GD365.66-3.84 (-1.04%) ▼|GE360.26+6.53 (+1.85%) ▲|GEV1,055.67-10.35 (-0.97%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.65+0.78 (+1.01%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.25+12.25 (+1.07%) ▲|HD341.56+3.82 (+1.13%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.18-5.89 (-2.71%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.03-6.82 (-2.69%) ▼|JPM347.02+4.13 (+1.20%) ▲|KO82.46-0.63 (-0.75%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.47+3.93 (+0.34%) ▲|LMT514.30-0.69 (-0.13%) ▼|LOW209.72+2.04 (+0.98%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.36-2.66 (-0.49%) ▼|MCD264.94-4.00 (-1.49%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.50+1.20 (+1.51%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.52+3.94 (+2.52%) ▲|MO70.51+0.35 (+0.50%) ▲|MRK123.60+2.82 (+2.33%) ▲|MS228.51+0.84 (+0.37%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.12-0.42 (-0.47%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.78-0.08 (-0.19%) ▼|NOW104.75-0.11 (-0.10%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.53+4.59 (+3.59%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.80+0.55 (+2.27%) ▲|PG148.01+1.93 (+1.32%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.87+4.92 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.59-1.37 (-1.43%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.27+1.20 (+0.22%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.50-0.59 (-0.41%) ▼|
35.6 C
New York
Wednesday, July 15, 2026

Tag: release

Ingredion 公布强劲的第二季度业绩,并上调全年业绩展望

韦斯特切斯特,伊利诺伊州, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的食品和饮料制造业配料解决方案供应商,Ingredion Incorporated(NYSE:INGR)今日公布其 2025 年第二季度业绩。

Ingredion Incorporated 第二季度業績表現穩健並提高全年展望

韋斯特切斯特,伊利諾州, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 全球頂尖的食品和飲料製造行業原料方案供應商 Ingredion Incorporated (NYSE: INGR) 今天發布了 2025 年第二季度的業績報告。

イングレディオン・インコーポレーテッド (Ingredion Incorporated)、堅調な第2四半期の決算を報告し、通期見通しを上方修正

イリノイ州ウエストチェスタ, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 食品飲料製造業を対象とした原材料ソリューションの世界トップクラスのプロバイダーであるイングレディオン・インコーポレーテッド (NYSE: INGR) は本日、2025年第2四半期の決算報告を行った。

Ingredion Incorporated Mencatat Prestasi Kukuh bagi Suku Kedua dan Menambah Baik Unjuran Tahunan

WESTCHESTER, Ill., Aug. 03, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), penyedia global terkemuka bagi penyelesaian ramuan untuk industri pembuatan makanan dan minuman, hari ini mengumumkan keputusan kewangan bagi suku kedua tahun 2025.

Ingredion Incorporated, 견조한 2분기 실적 발표 및 연간 전망 상향 조정

일리노이주 웨스트체스터, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 식품 및 음료 제조업계에 각종 원료 솔루션을 공급하는 글로벌 리더 Ingredion Incorporated(NYSE: INGR)가 2025년 2분기 실적을 발표했다

Ingredion Incorporated publie de solides résultats pour le deuxième trimestre et relève ses prévisions annuelles

WESTCHESTER, État de l’Illinois, 03 août 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE : INGR), l’un des principaux fournisseurs mondiaux de solutions d’ingrédients pour l’industrie alimentaire et des boissons, publie aujourd’hui ses résultats financiers du deuxième trimestre 2025.

Michael Owen Becomes the New Face of GK8: Fastest Growing iGaming Brand

SINGAPORE, Aug. 02, 2025 (GLOBE NEWSWIRE) -- GK8, Asia's leading platform for interactive gaming and entertainment, has proudly announced football legend Michael Owen as its newest brand ambassador. With a reputation built on trust, security, and a diverse range of gaming options, GK8 continues to expand its influence in the iGaming sector, and Owen's partnership is set to bolster its position in the competitive industry. Related link: https://youtu.be/9rTOPTyOcP0

XRP Crypto Powers Ahead in Global Payments — HashJ Introduces Participation Contracts for 2025 Users

London, United Kingdom, Aug. 02, 2025 (GLOBE NEWSWIRE) -- MGPD Finance Limited, doing business as HashJ, today announced the official rollout of its XRP participation contracts, offering users a simplified way to engage with one of the most established digital assets in global payments. This launch comes as XRP continues to demonstrate resilience and institutional appeal, buoyed by legal clarity and renewed adoption across financial sectors.

Pilly Labs Aligns with 2025 Demand for the Best Nutritional Gummies Supporting Whole Body Wellness

In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality.
In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality.

Presentation Unpacks the Advanced Technology Driving Elon Musk’s Starlink Network

Baltimore, MD, Aug. 02, 2025 (GLOBE NEWSWIRE) -- A presentation featuring James Altucher examines the engineering and technological breakthroughs behind Elon Musk’s Starlink project, highlighting how satellite architecture and hardware innovation could redefine global internet access.

Pilly Labs Formulates 2025’s Top Mushroom Extract Gummies Supplement for ADHD Focus, Anxiety Support, and Natural Weight Wellness

As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.
As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.

Collagen Supplement Trends in 2025: Why Pilly Labs Collagen Gummies Are Leading the Natural Glow-Up Movement

As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives.
As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fiserv, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FI

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

Chaga Mushroom Supplement Surge: Why Pilly Labs’ 2025 Formula Is Reshaping Immune Health Conversations

Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.
Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease